A Pediococcus acidilactici strain reduces weight loss and inflammation while restoring intestinal barriers.
Illumination devices excite nano-gold particles to break hydrogen bonds in water, forming stable small clusters without boiling.
Organic acids stabilize leflunomide by suppressing teriflunomide degradation during storage.
Steaming and defatting remove volatile essential oils from thyme, resolving stability issues while maintaining anti-inflammatory efficacy.
Sucrose and sorbitol prevent protein aggregation, maintaining bioactivity during long-term storage.
A cannabis-derived fraction containing at least 80% CBD, CBG, and THCV activates macrophages to modulate immune responses.
A plant extract composition attracts mesenchymal stem cells through chemotaxis to specific tissues.
Dissolves Crisaborole in propylene glycol to resolve chemical and physical stability issues in topical formulations for inflammatory skin conditions.
Bifidobacterium animalis subsp. lactis reduces abdominal pain in postmenopausal women.
Developing multiple crystalline polymorphs of the PARP14 inhibitor resolves formulation complexity while improving storage stability and bioavailability.
Pharmacokinetic modeling optimizes anifrolumab subcutaneous dosing to maintain efficacy while improving patient convenience over intravenous infusion.
A transmucosal film delivers dopamine agonists through the mucosal barrier.
Removing cell membranes from adipose-derived stem cells eliminates proliferation risks while maintaining hair regeneration and pain alleviation effects.